WO2021219569A1 - Système et procédé de test à distance - Google Patents

Système et procédé de test à distance Download PDF

Info

Publication number
WO2021219569A1
WO2021219569A1 PCT/EP2021/060870 EP2021060870W WO2021219569A1 WO 2021219569 A1 WO2021219569 A1 WO 2021219569A1 EP 2021060870 W EP2021060870 W EP 2021060870W WO 2021219569 A1 WO2021219569 A1 WO 2021219569A1
Authority
WO
WIPO (PCT)
Prior art keywords
data processing
test
processing means
location
immunity
Prior art date
Application number
PCT/EP2021/060870
Other languages
English (en)
Inventor
António Bernardino GUIMARÃES PARADA
Original Assignee
Magicroad, Lda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magicroad, Lda filed Critical Magicroad, Lda
Publication of WO2021219569A1 publication Critical patent/WO2021219569A1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/80—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for detecting, monitoring or modelling epidemics or pandemics, e.g. flu
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Definitions

  • the present invention relates to a system for testing administering a biological test to a person at a remote location.
  • Another aspect of the invention is a method for testing a person at a remote location.
  • SARS-CoV2 a pandemic caused by a new virus, referred to as SARS-CoV2.
  • the disease caused by the virus is referred to as Covid-19.
  • the virus causes a respiratory infection. In about 20% of infected patients the disease progresses to pneumonia. The disease is fatal in about 1- 2% of the cases.
  • the present invention relates to a system for remotely testing a subject for immunity to a contagious disease, said system comprising: a. at a first location: i. a data input means, comprising a camera; ii. a test kit for conducting an immunity test; b. at a second location: i. a data processing means; ii. a means for monitoring the first location during a test procedure; c. a data communication means connecting the first location and the second location.
  • the present invention relates to a method for remotely testing a subject for immunity to a contagious disease, said method comprising: a. at a first location, collecting identifying data of the subject; b. conveying the identifying data to a data processing means located at a second location via a data communication means connecting the first location and the second location; c. conducting a test procedure at the first location using a test kit; d. monitoring the test procedure at the second location using a camera located at the first location and communicating with the data processing means via the data communication means.
  • Figure 1 shows a schematic diagram of the system.
  • system refers to a combination of components configured to conduct and monitor a test procedure. Certain components are at a first location. Other components are at a second location, which is remote from the first location. A communication means allows monitoring at the second location a test procedure conducted at the first location.
  • remote and “remotely” as used herein refer to two locations, referred to as a first location and a second location, that are not within eyesight of each other.
  • the two locations may be different rooms within the same building. In most cases the two locations are not within the same building.
  • the two locations may be in different cities, in different countries, and even in different continents.
  • data input means means any device into which a user can enter data. Examples include computing devices, such as desktop computers, laptop computers, tablets, smart phones, and the like. Such computing devices may receive data via a keyboard, a touch screen, a microphone, a camera, or a combination of such interfaces. It is contemplated that, for use in the system of the present invention, the data input means comprises a camera.
  • the camera may form an integral part of the computing device, as is often the case with laptop computers, tablets and smart phones. In other embodiments the camera is physically separate from the computing device, and communicates with the computing device via a cable, for example a USB cable, or wirelessly, for example using Bluetooth or similar wireless protocol.
  • test kit refers to a combination of hardware components and/or chemicals to conduct a test, for example a biological test.
  • a test kit comprises a device for collecting a biological sample from the subject.
  • a test kit may further a cassette in which the test is carried out.
  • the cassette may contain all reagents and chemicals required to run the test.
  • the person conducting the test may be required to supply a test chemical that is not contained in the test kit, for example tap water.
  • the biological sample is a small amount of blood.
  • the test kit may comprise a lancet or other sharp device for pricking a finger of the subject, and a pipette for collecting a small amount of blood from the subject’s finger, transferring it to the cassette, and inserting it into the cassette at a re quired location.
  • biological sample refers to a specimen of biological material obtained from a test subject and suitable for conducting a test aimed at determining whether the subject possesses immunity.
  • the sample may be a tissue sample or an amount of a biological fluid. In many cases the sample is a small amount of blood, plasma, or serum.
  • data processing means refers to a device located at the second location that is configured to receive and process data. Examples include computers and servers, in particular web servers.
  • the term “means for monitoring the first location during a test procedure” refers to an algorithm present in the data processing means at the second location that is designed to receive and evaluate images from the camera at the first location.
  • the algorithm may serve one or several of the following functions: (i) identifying components of the test kit; (ii) certifying components of the test kit; (iii) collecting identifying parameters of the test subject; (iv) monitoring the test procedure; (v) certifying the integrity of the test procedure; (vi) making a video recording of the test procedure.
  • the algorithm may serve additional functions, as will be explained in the discussion of specific embodiments.
  • the algorithm may implement principles of artificial intelligence (Al).
  • data communication means refers to any data communication between the first and second locations. Examples include telephone lines, the Internet, and a mobile telephone network. It is the data connection that allows the several components to cooperate as a system. The data connection is temporary. It is established not long before the test procedure is started, and terminated not long after the test procedure is completed. The data processing means may participate in a number of systems contemporaneously.
  • identifying data refers to any data that may serve to identify the subject. Examples include names, date and place of birth, home address, and the like. The data must make it possible to identify the subject at the exclusion if all other human subjects, for example by containing information that is unique to the subject, such as a social security number and/or biometric data.
  • the data may contain a picture of the subject’s face; the picture may be incorporated in the immunity certificate. Biometric data may be incorporated, for example embedded, in the immunity certificate as well.
  • the term “immunity certificate” as used herein generally refers to a document identifying a human subject and certifying that the subject is deemed to possess a degree of immunity to a specified contagious disease.
  • the certificate may be protected against falsification and against unauthorized duplication.
  • the certificate may contain embedded data for identification, for example fingerprint data identifying the human subject for whom the certificate was issued.
  • the certificate may further contain data pertaining to date, time and place of its creation and the identity of the person who operated the apparatus when the certificate was created, to allow tracing and to facilitate fraud detection.
  • the purpose of the system is to allow a subject to undergo a biological test at any location from which a data connection to the data processing means can be established.
  • the system is established and controlled by a party that distributes test kits. This party will be referred to as the provider.
  • the person taking the test will be referred to as the user.
  • a liquid biological sample is introduced into a cassette, and migrates through a test film to which lines of antigen material (in the case of testing for the presence of antibodies) or antibody material (in the case of testing for the presence of an antigen) are adhered. Interaction of the antibody (or antigen) with its specific antigen (or antibody) results in a visible line in a read window of the cassette. Typically the cassette produces a control line to confirm proper functioning of the test.
  • the user purchases a test kit, for example at a pharmacy, or online.
  • a test kit for example at a pharmacy, or online.
  • the user may be asked to provide a photo ID, and the outside packaging of the test kit contains a scannable code, for example a bar code or a QR code, which is used to link the test kit to the user.
  • a scannable code for example a bar code or a QR code
  • the test kit contains usage instructions explaining the test procedure, as well as instructions for downloading an app issued by the provider.
  • the app is downloaded onto the user’s device (desktop computer, laptop computer, tablet, smartphone, or the like) the device becomes a data input means within the meaning of the present invention.
  • the user uses the app to establish a data connection with the data processing means (e.g. a web server) of the provider.
  • the provider wants to ensure the integrity of the test procedure. In particular, the provider wants to ensure that the test will be conducted with a biological sample of the user, and not of somebody else. In addition, the provider wants to ensure that the test result shown on the cassette is not tampered with.
  • the system for remotely testing a subject for a biological condition, comprises a first location 1 comprising a data input means 2 and a test kit 3 for conducting an immunity test; a second location 4 comprising a data processing means 5, a means for monitoring 6 of the first location during a test procedure; and a data communication means 7 connecting the first location and the second location.
  • the user is required to be alone in a room, and may be required to turn the camera around to show that nobody else is present.
  • the microphone of the user’s device must be turned on, and the provider’s data processing means conducts a sound check by emitting a sound and checks for its return via the user’s microphone.
  • the cassette contains a scannable code, such as a bar code or a QR code.
  • the scannable code is inextricably connected to the cassette, such that it cannot be removed without destroying it.
  • the user shows the cassette to the camera to confirm that the reader window is empty (no lines visible).
  • the user provides ID details to the data processing means, for example by filling out a form, showing a picture ID to the camera, allowing the camera to scan an optical code of a picture ID, taking his picture with the camera, using the camera to record a fingerprint, or any combination of such measures.
  • the data processing means may verify that the person presenting the test kit to the camera is the person that bought the test kit. As noted earlier, this feature is not necessary for proper functioning of the system, but may provide an additional layer of security.
  • the data processing means sends a message to the user’s app prompting the start of the test procedure.
  • the user must at all times be visible to the camera.
  • the scannable code of the cassette must also remain visible to the camera.
  • the user disinfects the tip of one finger and pierces it with a sharp device provided with the test kit.
  • the user then collects one or more drops of blood in a pipette or other device provided with the test kit, and transfers the blood to a well that is provided on the cassette for this purpose. Because both hands of the user are visible in the camera throughout this sequence of manipulations, the data processing means is able to confirm that the blood sample entered into the cassette originated from the user whose ID credentials have been recorded.
  • the blood sample After the blood sample has been introduced into the cassette it takes a certain amount of time, usually on the order of 10 to 20 minutes, for the lateral flow assay to produce a result. During this waiting time the user does not need to remain in front of the camera. But the cassette must remain visible to the camera throughout the entire test procedure.
  • the algorithm of the data processing means monitors the scene for any signs of tampering attempts. The user may be instructed not to touch the cassette during the waiting time to avoid false alarms.
  • the user shows the reading window of the cassette to the camera. At least one line must be visible in the reading window, the control line. If the control line is not visible the test is invalidated by the algorithm. If the control line is visible the test is considered valid.
  • test kit contains a direct solid-phase immunoassay
  • a visible test line connotes a positive result (i.e., the presence in the blood sample of the antigen or antibody of interest) and absence of a visible test line connotes a negative result (i.e. absence in the blood sample of the antigen or antibody of interest).
  • test kit contains a competitive solid-phase immunoassay
  • the absence of a visible test line connotes a positive result (i.e., the presence in the blood sample of the antigen or antibody of interest) and the presence of a visible test line connotes a negative result (i.e. absence in the blood sample of the antigen or antibody of interest).
  • the provider may distribute direct solid-phase immunoassay kits and competitive solid-phase immunoassay kits side-by-side, without identifying to the user which type of kit he or she is purchasing.
  • the data processing means uses the scannable code to determine the type of assay, and will be able to properly interpret the result.
  • the user is unable to determine the result. This discourages tampering, because adding a line or hiding a line could turn a desired result into an undesired result.
  • the lateral flow immunoassay may be of a multiplex type, capable of detecting more than one antigen or antibody in one sample.
  • an assay for SARS-CoV-2 antibodies may detect IgM and IgG antibodies.
  • the camera is used to scan the user’s fingerprint.
  • the data processing means uses minutiae of the fingerprint to convert the fingerprint into a numeric code.
  • the data processing means links the test result to the numeric fingerprint code.
  • the test is conducted completely anonymously. This may be desirable in a situation where two adults who meet for the first time want to engage in casual sex, but desire confirmation that the prospective sex partner does not carry a sexually transmitted disease (STD). They buy a test kit, for example from a vending machine or from the bartender of the bar where they just met. To conduct the test they may use a SIM-only mobile phone, or they may borrow a mobile phone that the bartender keeps for this purpose. The person to be tested conducts the test procedure, while the would-be sex partner monitors the procedure. The test taker provides a nickname to the data processing means. The data processing means returns a test result to the mobile phone, using the nickname to identify the result.
  • STD sexually transmitted disease
  • the data processing means may report the test result in one or more ways.
  • the result may be reported as a simple “positive” or “negative” to the user’s data input means. It may report the result to the user’s health care provider, insurance company, employer, parole officer, etc. It may produce an immunity certificate certifying that the user is deemed to possess immunity to a specific contagious disease, etc.
  • the provider distributes the test kits.
  • the provider distributes the app that is required for communication with the provider’s data processing means.
  • the provider interprets the test results and communicates the test results in a predetermined form.
  • the provider sets strict conditions for successful use of the system. The user is motivated to strictly comply with the rules set by the provider, because failure to do so may result in invalidation of the test and may even prompt a fraud investigation against the user.
  • a video recording may be stored in memory. Video recordings may be used for random audits by trained auditors. Alternately or additionally, the video footage may be monitored in real time by a trained auditor.
  • the data processing means may contain an algorithm that monitors the video footage for signs of potential fraud. The algorithm may rely on artificial intelligence (Al) to provide an ever-increasing level of sophistication of the monitoring function.
  • the data processing means may store an image of the user’s picture ID. If signs of potential fraud are detected, the provider may submit the image of the user’s picture ID to the authorities that issued the picture ID for verification. The data processing means may compare the user’s photo in the picture ID with an image of the user’s face produced by the camera.
  • the data processing means may use the camera to obtain a fingerprint of the user.
  • An algorithm present in the data processing means converts the fingerprint data to a unique numeric code, which is stored in memory.
  • the system and method of this invention can be used in slowing or preventing the spread of any contagious disease.
  • the disease may by caused by any pathogen, for example a bacterium, a virus, a fungus, or a parasite. Examples include respiratory diseases, hepatitis, yellow fever, Ebola, sexually transmitted diseases, and the like.
  • the contagious disease is caused by a virus, for example a corona virus.
  • the virus is SARS-CoV2.
  • the system and method can be used for drug testing. With proper consent of the user, the user produces a urine sample in the privacy of his or her home, while being monitored by the camera. This embodiment requires a high standard of data protection. Depending on local laws, the video footage may not be made available for viewing by a person.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Primary Health Care (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La présente invention concerne un système et un procédé pour tester à distance une condition biologique d'un sujet, telle qu'une infection par une maladie contagieuse ou une immunité contre une maladie contagieuse. Le système utilise la caméra d'un dispositif informatique commandé par le sujet pour surveiller la procédure de test.
PCT/EP2021/060870 2020-04-27 2021-04-26 Système et procédé de test à distance WO2021219569A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063015685P 2020-04-27 2020-04-27
US63/015,685 2020-04-27

Publications (1)

Publication Number Publication Date
WO2021219569A1 true WO2021219569A1 (fr) 2021-11-04

Family

ID=75769553

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2021/060870 WO2021219569A1 (fr) 2020-04-27 2021-04-26 Système et procédé de test à distance

Country Status (1)

Country Link
WO (1) WO2021219569A1 (fr)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002059364A1 (fr) * 2001-01-27 2002-08-01 Electron-Bio, Inc. Procede et dispositif d'analyses d'hybridation nucleique faisant appel a une technique de clivage reagissant au double brin ou au simple brin complementaire d'acides nucleiques ou d'oligonucleotides
US20020118355A1 (en) * 2000-11-08 2002-08-29 Worthington Mark Oscar Interactive system for analyzing biological samples and processing related information and the use thereof
WO2006121266A1 (fr) * 2005-05-06 2006-11-16 Jae Chern Yoo Biodisque numerique (dbd), appareil de lecture de dbd, ainsi que procede d'analyse mettant en oeuvre ce biodisque
WO2007001160A1 (fr) * 2005-06-28 2007-01-04 Jae Chern Yoo DISPOSITIF DE BlOLECTURE ET PROCÉDÉ D’ESSAI L’UTILISANT
EP2140412A1 (fr) * 2007-04-23 2010-01-06 Ltd. Samsung Electronics Co. Système et procédé de télédiagnostic médical
US20190201900A1 (en) * 2017-12-11 2019-07-04 Sensor Kinesis Corp. Apparatus for automatic sampling of biological species employing disk microfluidics system
US20190384890A1 (en) * 2018-06-15 2019-12-19 Reliant Immune Diagnostics, Inc. System and method for digital remote primary, secondary, and tertiary color calibration via smart device in analysis of medical test results

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020118355A1 (en) * 2000-11-08 2002-08-29 Worthington Mark Oscar Interactive system for analyzing biological samples and processing related information and the use thereof
WO2002059364A1 (fr) * 2001-01-27 2002-08-01 Electron-Bio, Inc. Procede et dispositif d'analyses d'hybridation nucleique faisant appel a une technique de clivage reagissant au double brin ou au simple brin complementaire d'acides nucleiques ou d'oligonucleotides
WO2006121266A1 (fr) * 2005-05-06 2006-11-16 Jae Chern Yoo Biodisque numerique (dbd), appareil de lecture de dbd, ainsi que procede d'analyse mettant en oeuvre ce biodisque
WO2007001160A1 (fr) * 2005-06-28 2007-01-04 Jae Chern Yoo DISPOSITIF DE BlOLECTURE ET PROCÉDÉ D’ESSAI L’UTILISANT
EP2140412A1 (fr) * 2007-04-23 2010-01-06 Ltd. Samsung Electronics Co. Système et procédé de télédiagnostic médical
US20190201900A1 (en) * 2017-12-11 2019-07-04 Sensor Kinesis Corp. Apparatus for automatic sampling of biological species employing disk microfluidics system
US20190384890A1 (en) * 2018-06-15 2019-12-19 Reliant Immune Diagnostics, Inc. System and method for digital remote primary, secondary, and tertiary color calibration via smart device in analysis of medical test results

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ASSIS RAFAEL R ET AL: "Analysis of SARS-CoV-2 Antibodies in COVID-19 Convalescent Plasma using a Coronavirus Antigen Microarray", BIORXIV : THE PREPRINT SERVER FOR BIOLOGY, 17 April 2020 (2020-04-17), pages 1 - 21, XP055800069, Retrieved from the Internet <URL:https://www.biorxiv.org/content/10.1101/2020.04.15.043364v1.full.pdf> [retrieved on 20210429], DOI: 10.1101/2020.04.15.043364 *
KHAN SAAHIR ET AL: "Analysis of Serologic Cross-Reactivity Between Common Human Coronaviruses and SARS-CoV-2 Using Coronavirus Antigen Microarray", BIORXIV : THE PREPRINT SERVER FOR BIOLOGY, 25 March 2020 (2020-03-25), pages 1 - 10, XP055800048, Retrieved from the Internet <URL:https://www.biorxiv.org/content/10.1101/2020.03.24.006544v1.full.pdf> [retrieved on 20210429], DOI: 10.1101/2020.03.24.006544 *

Similar Documents

Publication Publication Date Title
US11238722B2 (en) Methods and systems for providing online monitoring of released criminals by law enforcement
US5897989A (en) Method, apparatus and system for verification of infectious status of humans
US8401875B2 (en) Secured personal data handling and management system
US10043229B2 (en) Method for confirming the identity of an individual while shielding that individual&#39;s personal data
US20120086785A1 (en) Apparatus for identifying protecting, requesting, assisting and managing information
US20030163708A1 (en) Method and system for detecting and eliminating fraud
KR20180050968A (ko) 온라인 시험 관리 방법
CN107025397A (zh) 身份信息的获取方法和装置
EP4154168A1 (fr) Systèmes d&#39;authentification biométrique sans contact et procédés associés
Stafylis et al. Vending machines in commercial sex venues to increase HIV self-testing among men who have sex with men
WO2017180634A1 (fr) Système automatisé de libération conditionnelle, de probation et de supervision communautaire
McAllister et al. Effects of lineup modality on witness credibility
WO2021257909A1 (fr) Systèmes et procédés de contrôles routiers virtuels
WO2010030431A2 (fr) Procédé permettant de confirmer l&#39;identité d&#39;une personne tout en masquant les données personnelles de cette personne
WO2021219569A1 (fr) Système et procédé de test à distance
TWI802036B (zh) 疫苗施打資料顯示方法、疫苗施打資料顯示系統和疫苗施打資料驗證伺服器
NL2027869B1 (en) Apparatus and method for producing immunity certificates
CN109509546A (zh) 基于生物识别的身份认证方法、装置、终端及介质
Clark The role of physicians as medical review officers in workplace drug testing programs. In pursuit of the last nanogram.
KR20230173710A (ko) 자가 샘플링 관리용 전자 장치, 자가 샘플링 관리 방법 및 이러한 방법을 수행하기 위한 컴퓨터 프로그램을 저장하는 컴퓨터 판독가능한 기록매체
Vuokko et al. Typology-based analysis of covid-19 mobile applications: implications for patient empowerment
Bracken et al. Detection and Remediation of Malicious Actors for Studies Involving Remote Data Collection.
Caines The many faces of facial recognition
Zhang et al. Healthcare costs for legally adjudicated elder mistreatment victims in comparison to non‐mistreated older adults
US20240038047A1 (en) Personal surveillance device, system and method

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21722784

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21722784

Country of ref document: EP

Kind code of ref document: A1